Evidence map›Paper›PMID 38664017›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2024

Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [

Clemens Mingels, Benjamin A Spencer, Hande Nalbant, Negar Omidvari, Mehrad Rokni, Axel Rominger, Fatma Sen, Simon R Cherry, Ramsey D Badawi, Yasser G Abdelhafez and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. How can children benefit from total-body PET?The British journal of radiology · 2026
    Review
  3. Article
  4. Article
  5. Lesion conspicuity by size in [EJNMMI research · 2026
    Article
  6. Total Body PET.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  7. Review
  8. Lymphoma Therapy Response Assessment with Low-Dose [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  9. A scoping review on potential of novel developments in fever of unknown origin and inflammation of unknown origin: long-axial-field-of-view positron emission tomography/computed tomography and novel radiotracers.The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... · 2025
    Article
  10. Diagnostic accuracy in NSCLC lymph node staging with Total-Body and conventional PET/CT.European journal of nuclear medicine and molecular imaging · 2025
    Article
  11. Article
  12. Expert consensus on workflow of PET/CT with long axial field-of-view.European journal of nuclear medicine and molecular imaging · 2025
    Review
  13. Review
  14. Quantitative Accuracy Assessment of the NeuroEXPLORER for Diverse Imaging Applications: Moving Beyond Standard Evaluations.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  15. Total Body PET/CT: Future Aspects.Seminars in nuclear medicine · 2025
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Clemens MingelsDepartment of Radiology, University of California Davis, Sacramento, California; clemens.mingels@insel.ch.
Benjamin A SpencerDepartment of Radiology, University of California Davis, Sacramento, California.
Hande NalbantDepartment of Radiology, University of California Davis, Sacramento, California.
Negar OmidvariDepartment of Biomedical Engineering, University of California Davis, Davis, California; and.
Mehrad RokniDepartment of Radiology, University of California Davis, Sacramento, California.
Axel RomingerDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Fatma SenDepartment of Radiology, University of California Davis, Sacramento, California.
Simon R CherryDepartment of Radiology, University of California Davis, Sacramento, California.
Ramsey D BadawiDepartment of Radiology, University of California Davis, Sacramento, California.
Yasser G AbdelhafezDepartment of Radiology, University of California Davis, Sacramento, California.
Lorenzo NardoDepartment of Radiology, University of California Davis, Sacramento, California.
University of California, Davis · USUniversity of Bern · CH

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI KC KENT LLOYD · 2002 to 2026
$84.9M
Basic applications for total-body PET in oncologyR01CA249422 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BADAWI, RAMSEY D., NARDO, LORENZO · 2019 to 2023
$3.1M
NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA249422
6 · The paper itself

Abstract

Our aim was to define a lower limit of reduced injected activity in delayed [

Indexed as

Fluorodeoxyglucose F18NeoplasmsPositron Emission Tomography Computed TomographyRadiation DosageWhole Body ImagingAdolescentChildChild, PreschoolFemaleHumansImage Processing, Computer-AssistedMaleProspective StudiesRadiopharmaceuticalsSignal-To-Noise RatioTime FactorsFluorodeoxyglucose F18Radiopharmaceuticals[18F]FDGdose reductionlong-axial-field-of-view PET/CTpediatric oncologytotal-body PET/CT

Identifiers

PMID38664017
PMCPMC11218730
OpenAlexW4395479683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.